Early results of new studies of GlaxoSmithKline’s (GSK) blockbuster antidepressant Paxil (paroxetine) show an increase in the risk of congenital birth defects when pregnant mothers taking the drug ...

Sept. 28, 2005 — The U.S. Food and Drug Administration (FDA) and GlaxoSmithKline have warned healthcare professionals via letter regarding the potential risk of major congenital malformations in ...

LONDON (Reuters) - GlaxoSmithKline said on Tuesday it had agreed to settle certain U.S. lawsuits alleging its Paxil antidepressant caused birth defects in some patients but declined to put a figure on ...

Popular antidepressants Paxil and Prozac are linked to higher rates of birth defects, but several similar drugs used to treat depression in pregnant women carry no such risks, a new study found. The ...

July 9 (Reuters) - A sweeping government study of thousands of women has found links between the older antidepressants Prozac and Paxil and birth defects, but has cleared other popular treatments in ...

In a setback for GlaxoSmithKline, the same federal judge who recently remanded eight Paxil birth defect suits to state court has now been assigned by his chief judge to decide the fate of another 21 ...

The Food and Drug Administration warned pregnant women and their doctors away from the antidepressant Paxil yesterday because of an increased risk of heart defects in newborns. With the warning, the ...

A new study is revealing more about anti-depressants and the potential impact they can have on unborn babies. The study by the CDC found a slight increase in birth defects in babies born to women ...

The maker of the antidepressant Paxil has been hit with five new lawsuits claiming that use of the drug by pregnant women caused heart defects in their children, leading to the deaths of three of the ...